Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

Identification of a Novel LysR-Type Transcriptional Regulator in Staphylococcus aureus That Is Crucial for Secondary Tissue Colonization during Metastatic Bloodstream Infection

Michaela Groma, Sarah A. Horst, Sudip Das, Bruno Huettel, Maximilian Klepsch, Thomas Rudel, Eva Medina, Martin Fraunholz
Paul D. Fey, Invited Editor, Michael S. Gilmore, Editor
Michaela Groma
aChair of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah A. Horst
bHelmholtz-Zentrum für Infektionsforschung, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudip Das
aChair of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
dDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Huettel
cMax Planck Genome Centre, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maximilian Klepsch
aChair of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Rudel
aChair of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
eHelmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Medina
bHelmholtz-Zentrum für Infektionsforschung, Braunschweig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Fraunholz
aChair of Microbiology, Biocenter, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Fraunholz
Paul D. Fey
University of Nebraska Medical Center
Roles: Invited Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Gilmore
Harvard Medical School
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.01646-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Staphylococcus aureus is a common cause of bacteremia that can lead to severe complications once the bacteria exit the bloodstream and establish infection in secondary organs. Despite its clinical relevance, little is known about the bacterial factors facilitating the development of these metastatic infections. Here, we used an S. aureus transposon mutant library coupled to transposon insertion sequencing (Tn-Seq) to identify genes that are critical for efficient bacterial colonization of secondary organs in a murine model of metastatic bloodstream infection. Our transposon screen identified a LysR-type transcriptional regulator (LTTR), which was required for efficient colonization of secondary organs such as the kidneys in infected mice. The critical role of LTTR in secondary organ colonization was confirmed using an isogenic mutant deficient in the expression of LTTR. To identify the set of genes controlled by LTTR, we used an S. aureus strain carrying the LTTR gene in an inducible expression plasmid. Gene expression analysis upon induction of LTTR showed increased transcription of genes involved in branched-chain amino acid biosynthesis, a methionine sulfoxide reductase, and a copper transporter as well as decreased transcription of genes coding for urease and components of pyrimidine nucleotides. Furthermore, we show that transcription of LTTR is repressed by glucose, is induced under microaerobic conditions, and required trace amounts of copper ions. Our data thus pinpoints LTTR as an important element that enables a rapid adaptation of S. aureus to the changing host microenvironment.

IMPORTANCE Staphylococcus aureus is an important pathogen that can disseminate via the bloodstream and establish metastatic infections in distant organs. To achieve a better understanding of the bacterial factors facilitating the development of these metastatic infections, we used in this study a Staphylococcus aureus transposon mutant library in a murine model of intravenous infection, where bacteria first colonize the liver as the primary infection site and subsequently progress to secondary sites such as the kidney and bones. We identified a novel LysR-type transcriptional regulator (LTTR), which was specifically required by S. aureus for efficient colonization of secondary organs. We also determined the transcriptional activation as well as the regulon of LTTR, which suggests that this regulator is involved in the metabolic adaptation of S. aureus to the host microenvironment found in secondary infection sites.

INTRODUCTION

Staphylococcus aureus is a common colonizer of the human skin and mucosal membranes without causing diseases. However, S. aureus can also cause a variety of severe infections such as sepsis, abscesses in deep tissues, and osteomyelitis after reaching sterile anatomic sites, for example, via the bloodstream (1). The emergence and spread of S. aureus strains resistant to multiple antibiotics (2) added to the remarkable capacity of S. aureus to evade elimination by the host immune defenses (3) and make this pathogen a formidable challenge for physicians. Despite extensive efforts made by the research community to uncover the pathogenic strategies of S. aureus, many aspects of the infection process remain unclear. In metastatic bloodstream infections, S. aureus disseminates from a primary site of infection such as skin abscesses, intravenous catheters, or surgical sites to secondary organs (4). Several virulence factors have been reported to mediate the interaction and/or extravasation of S. aureus through the endothelium, including the extracellular adherent protein Eap, wall teichoic acid, or fibronectin-binding proteins (5). After extravasation from the bloodstream to adjacent tissue, S. aureus must adapt to the physicochemical microenvironment and nutrient availability as well as to the local immune response in the new niches in order to survive, proliferate, and establish productive infection. The virulence mechanisms of S. aureus that facilitate these processes remain largely unknown. A deeper understanding of these pathogenic mechanisms can provide novel opportunities for therapeutic interventions in bacteremic patients.

We previously reported the remarkable plasticity of S. aureus to reprogram its expression of virulence factors during infection to adapt to the microenvironment and to the biological pressure imposed by the host (6, 7). In this study, we have used a S. aureus transposon insertion library coupled to deep sequencing of transposon insertion sites (Tn-Seq) to identify genes required by S. aureus to colonize and establish infection in secondary organs during in vivo infection. In general, Tn-Seq has become a very popular high-throughput technique that has been widely applied to identify genes and pathways that are important for infection for different pathogens (8–10). We and others have successfully applied this technique to identify novel factors involved in S. aureus pathogenicity (11, 12). Thus, in a previous study using a transposon mutant library generated with the staphylococcal strain 6850, we identified the araC-type transcriptional regulator repressor of surface proteins rsp as a pleiotropic virulence factors regulator during the initial stages of infection (11). Here, we screened this S. aureus transposon insertion library (11) in a well-established mouse model of metastatic bloodstream infection (13). Mice were infected with the mutant library, and the mutants recovered from the primary site of infection, the liver, as well as from the secondary infected organs, the kidneys in this case, were compared with those present in the original inoculum. The mutants underrepresented in the pool of colonizing bacteria in comparison with the original inoculum indicated the genetic determinants that are critical for optimal establishment of infection in secondary organs. A single gene was identified (RSAU_000852) that encoded a LysR-type transcriptional regulator (LTTR), whose mutants were specifically depleted in the bacterial pool recovered from the kidneys. An isogenic mutant in LTTR exhibited a significantly reduced capacity to survive in kidneys and tibiae compared to that of the wild type, thus corroborating the results of the Tn-Seq analysis. Functional characterization of LTTR indicated that this regulator may be required by S. aureus to rapidly adjust to the environmental conditions and nutrient availability in secondary organs.

RESULTS

Tn-Seq identifies a novel transcriptional regulator of S. aureus required for colonization of secondary organs.To identify factors required for S. aureus colonization of secondary organs during bloodstream infection, mice were intravenously infected with 106 CFU of a transposon mutant library of S. aureus strain 6850 (11), livers and kidneys were isolated from infected mice (n = 3) at 24 h after bacterial inoculation, and organ homogenates were plated onto blood agar. The numbers of bacteria at the time of sampling were 4.86 ± 0.69 log10 CFU in livers and 5.3 ± 0.7 log10 CFU in kidneys. Bacteria were collected from the plates and pooled, and enrichment or depletion of bacterial insertional mutants in kidneys and livers of infected mice was assessed by deep-sequencing of transposon insertion sites (Tn-Seq).

Of the five genes (RSAU_000958 [purM], RSAU_000901, RSAU_000571 [ltaA], a hypothetical protein RSAU_000852, and RSAU_002542, a putative DNA-binding protein) whose mutants were significantly depleted in bacteria recovered from the kidneys in comparison to that in the inoculated mutant pool (Table 1), four were also found depleted in the liver: RSAU_000958, RSAU_000901, RSAU_000571, and RSAU_002542 (see Tables S4 to S6 in the supplemental material). Whereas purM and ItaA are genes with known functions and involved in pathways that are important for the physiology of S. aureus, such as purine biosynthesis and the cell wall, respectively, RSAU_000852 (NCTC8325 identifier [ID] SAOUHSC_00913), whose mutant was depleted only in the kidneys, was a novel gene with unknown function. Because this gene is homologous to a gene encoding a LysR-type transcriptional regulator, RSAU_000852 was termed LysR-type transcriptional regulator (LTTR). Mutants in LTTR were significantly depleted in bacteria recovered from kidneys (log2 fold change [log2FC], 3.95; P = 5.6 × 10−7), whereas read counts obtained from liver did not differ significantly from those of the inoculum (log2FC = 0.18, P = 0.84) (Fig. 1). Sequence alignments indicated that LTTR is highly conserved in S. aureus, where sequence variants share at least 96% identity on the amino acid level. In addition to S. aureus, homologues were also observed in the closely related species Staphylococcus schweitzeri and Staphylococcus argenteus, with slightly different gene variants being observed in S. argenteus (84% to 87% of amino acid sequence identity between S. argenteus and S. aureus proteins) (data not shown). Since the gene is highly conserved in S. aureus, we focused our efforts on the functional characterization of this novel regulator that seems to be critical for the fitness of S. aureus during colonization of secondary organs. For this purpose, we generated an isogenic knockout mutant within the S. aureus strain 6850 deficient in the expression of LTTR (Δ852). By genome sequencing, we excluded the introduction of secondary site mutations during the mutagenesis procedure, since the method involved selection of an integrative plasmid under non-permissive conditions (treatment at 42°C), which had been shown to result in mutations within the sae two-component system.

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

List of genes identified based on the enrichment or depletion of the respective transposon mutant in murine kidneys with respect to that in the intravenously inoculated transposon mutant pool

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

The frequency of S. aureus with mutation in RSAU_000852 is significantly lower in the bacterial pool recovered from infected kidneys than in the original inoculum. C57BL/6 mice (n = 3) were intravenously infected with a S. aureus 6850 transposon mutant library, and viable bacteria were recovered from liver and kidneys at 24 h of infection. Pools of the recovered bacteria and the respective inoculum (input) were analyzed by Tn-Seq, and counts of transposon insertion sites were compared by DESeq2. ***, P < 0.001.

LTTR is important for S. aureus successful colonization of secondary infection sites.To validate the results of the transposon mutant screen, we compared the capacity of S. aureus Δ852 to establish infection in secondary organs after intravenous inoculation to that of the wild-type (WT) strain. Whereas CFU of WT and mutant strain recovered from livers did not differ significantly (Fig. 2A), the numbers of bacteria recovered from kidneys (Fig. 2B) and bones (Fig. 2C) were significantly lower in mice infected with the Δ852 strain than in those infected with the WT strain. The serum levels of the inflammatory cytokine interleukin 6 (IL-6) were significantly lower in mice infected with the Δ852 strain than in mice infected with the wild-type strain, further corroborating the attenuated phenotype of the Δ852 mutant (Fig. 2D). These results supported the requirement of LTTR for successful S. aureus infection of secondary organs during bloodstream infection.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

LTTR is required by S. aureus for successful infection of secondary organs. Mice were infected intravenously with WT (●) and Δ852 (▲), and CFU where determined in liver (A), kidneys (B) and tibiae (C) at 24 h of infection. Each symbol represents the data of an individual animal. Data are pooled from three independent experiments. (D) Serum levels of IL-6 in uninfected or in mice infected with either wild-type or Δ852 mutant strain at 24 h of infection. Each column represents the mean values ± standard deviations (SDs) from three independent experiments. *, P < 0.05; **, P < 0.01; ****, P < 0.001.

Characterization of the regulon of the novel LTTR.To identify the regulon controlled by LTTR, S. aureus WT and S. aureus Δ852 were transduced with an anhydrous tetracycline (AHT)-inducible plasmid (14) carrying LTTR (WT_AHT and Δ852_AHT, respectively). The gene expression profile of S. aureus WT, Δ852, WT_AHT, and Δ852_AHT strains cultured in Trypticase soy broth (TSB) was analyzed using transcriptome sequencing (RNA-seq) after inducing LTTR expression by addition of 200 ng/ml of AHT for 1 h and the genes differentially expressed between the different strains were assessed by DESeq2 analysis. Several transcripts were found specifically up- and downregulated upon induction of LTTR (Table 2). Genes upregulated upon induction of LTTR expression included peptide methionine sulfoxide reductase msrA2, the components of a copper-translocation machinery copA and copZ, the genes of branched-chain amino acid biosynthesis ilvD, ilvB, and leuA2, and the holin-like murein hydrolase regulator lrgA. The genes with reduced expression after LTTR induction included members of the urease operon (ureB, ureC, ureE, and ureF), genes of pyrimidine biosynthesis pathway (pyrB, pyrC, and carB), the gene coding for tagatose-6-phosphate kinase (lacC) and phosphotransferase system (PTS) lactose-specific transporter subunit IIBC (lacE). The upregulation of LTTR in Δ852_AHT after treatment with AHT was validated by reverse transcription-PCR (RT-PCR) (Fig. 3A). Furthermore, the expression of a set of genes found in the RNA-seq data either upregulated (msrA, copA, lrgA, and RNAIII) or downregulated (leuA2, ureC, leuA1, carB, lacC, and pyrB) after LTTR induction in WT-AHT versus that in the Δ852 strain were also confirmed by RT-PCR (Fig. 3B).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 2

Regulated genes upon induced expression of LTTRa

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Validation of RNA-seq data by quantitative RT-PCR. (A) Expression level of LTTR (RSAU_000852) in S. aureus WT + AHT, Δ852 and WT p2085-852 + AHT relative to the expression in the WT strain after stimulation of LTTR expression with 200 ng/ml AHT for 1 h (n = 3). Notice the similar levels of LTTR expression in WT and WT + AHT and the almost undetectable level in Δ852. (B) Expression level of a set of genes in WT p2085-852 (+ AHT) relative to the expression in Δ852. Statistical analysis was performed using Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

Using the genes’ ortholog identifiers for strain NCTC8325, we found that the potential LTTR target genes were significantly enriched in gene ontology (GO) terms for the biological processes “branched-chain amino acid biosynthetic process” (GO:0009082), “urea metabolic process (GO:0019627), and “de novo uridin monophosphate (UMP) biosynthetic process” (GO:0044205) (see Table S3).

Transcription of LTTR is enhanced under infection-mimicking conditions.To investigate under which conditions LTTR is expressed by S. aureus, a promoter fusion with a codon-adapted green fluorescent protein (GFP) (15) was generated yielding the plasmid p2085-Pr852-GFP that was introduced into S. aureus WT. Because oxygen levels at sites of tissue inflammation may be relatively low as a result of impaired perfusion (16), we recorded bacterial growth and GFP fluorescence levels under aerobic and microaerobic conditions. No differences were observed in bacterial growth under aerobic or microaerobic conditions (see Fig. S1A). However, promoter activity was stronger in bacteria grown under microaerobic conditions than in those grown under aerobic conditions (Fig. S1B and C). We therefore determined the levels of transcription of LTTR in S. aureus WT grown in TSB under aerobic and microaerobic conditions and found the transcription levels of the gene to be significantly higher under microaerobic conditions than when grown in the presence of oxygen (Fig. S1D).

FIG S1

Microaerophily has a positive effect on the promotor expression of LTTR. (A) Kinetics of S. aureus WT growth determined by OD600 under microaerobic (lighter color) or under aerobic (darker color) conditions (n = 3). (B) Mean fluorescence of the GFP linked to the LTTR promoter region in S. aureus WT under microaerobic (lighter color) or under aerobic (darker color) conditions. (C) Ratio of GFP to OD (GFP/OD) is higher under microaerobic conditions. (D) Relative transcription level of LTTR in S. aureus WT grown in TSB for 6 h under aerobic or microaerobic conditions. (E) GFP/OD ratios of wild-type S. aureus 6850 in CDM under microaerobic (light grey) or aerobic conditions (dark grey). Statistical analysis was performed using Student’s t test. **, P < 0.01. Download FIG S1, PDF file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Interestingly, during the process of generating the GFP reporter strain, we observed that S. aureus Pr852-GFP plated on LB agar without glucose exhibited more intense GFP fluorescence than when it was grown in TSB agar containing 2.5 g/liter glucose (Fig. 4A). Similarly, we observed difference during growth in broth as shown by the slightly faster bacterial growth in glucose-free LB medium than in TSB containing 2.5 g/liter glucose. The mid-log phase was reached after 3 h in LB and after 7 h of culture in TSB (Fig. 4B). Again, promoter activity of Pr852 was drastically increased in LB in comparison to that in TSB (Fig. 4C and D). To investigate the repression by glucose, we grew WT and mutant bacteria in chemically defined medium (CDM) containing various concentrations of glucose ranging from 0 to 75 mM. We recorded bacterial growth as well as Pr852 promoter activity over a period of 24 h (Fig. 4E). Addition of 10 mM glucose resulted in ∼50% reduction of promoter activity, which was almost completely abolished at 50 mM and 75 mM glucose. Our results hereby indicated that the promoter of LTTR was repressed by glucose.

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Transcription of LTTR is repressed by glucose. (A) GFP fluorescence of S. aureus 6850 harboring the LTTR promoter reporter plasmid Pr852-GFP is less intense in TSB agar containing 2.5 g/liter glucose (left) than in glucose-free LB agar (right). (B to D) Kinetics of S. aureus 6850 Pr852-GFP growth determined over a 24 h period under microaerobic conditions in either glucose-containing TSB or glucose-free LB medium. The changes in OD600 are shown in panel B, the mean GFP fluorescence in panel C and the GFP/OD ratios in panel D. (E) GFP/OD ratios after 24 h of culture of the promoter reporter strain grown under microaerobic conditions in CDM supplemented with different glucose concentrations showing a concentration-dependent repression of the LTTR promoter by glucose. Each kinetics experiment was performed in triplicates (n = 3). Statistical analysis was performed using Student’s t test. **, P < 0.01; ***, P < 0.001.

To investigate additional nutritional requirements for LTTR transcription, we used CDM and determined LTTR promoter activity by the levels of GFP fluorescence. We first corroborated that promoter activity was enhanced under microaerobic conditions in CDM (Fig. S1E) and increased in the absence of glucose (Fig. 5A). We next determined LTTR promoter activity in CDM without glucose and omitting other components of the defined medium. Upon omission of the trace metal mixture, we identified reduced LTTR activity (Fig. 5A). We thus omitted single constituents of the trace mixture, including boric acid, manganese(II) chloride, zinc sulfate, sodium molybdate, cobalt nitrate, or copper sulfate (Fig. 5B; see Fig. S2A to F). LTTR promoter activity was abolished only in CDM without copper sulfate but showed a dose-dependent increase upon addition of different concentrations of copper sulfate and was fully reconstituted by addition of 400 nM copper sulfate (Fig. 5C and D). Similarly, the relative transcription level of LTTR in strains grown in CDM without glucose (Δglucose) compared to that in CDM additionally lacking copper sulfate (CDM Δglucose Δcopper) demonstrated that the transcription level of LTTR is significantly higher in S. aureus WT (threshold cycle difference [ΔΔCT] = 2.375 ± 0.1737, P value = 0.0014) as well as in Δ852 bacteria carrying the complementation plasmid pI852 (ΔΔCT = 2.527 ± 0.1795, P value = 0.0010) when copper sulfate was present in the medium (Fig. S2G).

FIG 5
  • Open in new tab
  • Download powerpoint
FIG 5

LTTR promoter activity is observed under infection-mimicking conditions and requires copper ions. (A) GFP/OD ratios of wild-type S. aureus 6850 growing under microaerobic conditions in full CDM (light gray), CDM lacking glucose (blue), or lacking both glucose and trace elements (green). (B) Microaerobic growth in glucose-free CDM lacking single constituents of the trace element mixture identifies a copper requirement for promoter activity. (C) Copper-dependent dose response of the LTTR promoter is observed during microaerobic growth in glucose-free CDM and increasing amounts of copper sulfate ranging from 0 to 1,000 nM. (D) 400 nM copper sulfate restores full promoter activity, whereas lower concentrations show a significant dose-dependent decrease in promoter activities. (E) The LTTR promoter is induced by 25 mM hydrogen peroxide. Relative transcription level of the different strains under uninduced (black bars) conditions or after treatment with 25 mM H2O2 for 1 h (gray bars). Each experiment was performed in triplicates (n = 3). Statistical analysis was performed using Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

FIG S2

LTTR 852 Promotor activity under microaerobic conditions in CDM without glucose and trace elements illustrates the requirement of copper. GFP/OD ratio of S. aureus p852 GFP in glucose-free CDM lacking either boric acid (A), manganese(II) chloride (B), zinc sulfate (C), sodium molybdate (D), cobalt(II) nitrate (E), or copper sulfate (F). (G) Significantly higher expression of LTTR in the wild type and complement is observed when strains are grown in CDM Δglucose in the presence of copper sulfate. Depicted are relative transcription levels of LTTR in wild type (WT) and complement (pl852) strains with or without copper sulfate. Mutant expression levels were set to 1. Statistical analysis was performed using Student’s t test. **, P < 0.01. Download FIG S2, PDF file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

Our RNA-seq data after induced expression of LTTR identified the oxidative stress response gene msrA2 as a target gene. We therefore hypothesized that LTTR may be important for S. aureus upon encounter of oxidative stress in the host. To test this hypothesis, we compared the levels of LTTR gene RSAU_000852 transcription between S. aureus WT, the Δ852 mutant, and the complemented mutant grown under normal growth conditions and under oxidative stress conditions generated after a pulse with 25 mM hydrogen peroxide for 1 h. Transcriptional expression of the well-known oxidative stress response genes dps and sodA was used to corroborate that peroxide exposure induced an oxidative stress response in S. aureus (see Fig. S3). Transcription of RSAU_000852 was induced in the WT (2.69 [± 0.05]-fold induction; P value < 0.0001) and the complement strain (2.35 [± 0.13]-fold induction; P value = 0.0004) under H2O2 stress, which was absent in the Δ852 mutant (Fig. 5E).

FIG S3

LTTR transcription is induced by peroxide stress: relative transcription levels of dps and sodA show induction of oxidative stress. Relative transcription level of the S. aureus 6850 WT, the LTTR mutant (Δ852), and the complementation strain (pI852) under normal growth conditions (black bars) or after treatment with 25 mM H2O2 for 1 h (grey bar). General stress protein dps (A) and superoxide dismutase sodA (B) are induced demonstrating a transcriptional response of S. aureus to reactive oxygen species. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Download FIG S3, PDF file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

DISCUSSION

After invasion of the host, pathogens need to rapidly adjust to the different tissue microenvironments encountered during the infection process in order to successfully establish infections. This involves sensing local conditions, including nutrient availability and resident host immune defenses, and adjusting their gene expression and virulence functions accordingly. Thus, within the infection niches in the host, pathogens need to overcome barriers that sharply limit their population size, the so-called bottlenecks. For example, after intravenous inoculation, S. aureus quickly accumulates within the liver, which constitutes the first infection niche of the host. Within the liver, a high proportion of the inoculated bacteria are sequestered by Kupffer cells, which are liver macrophages and represent the first infection bottleneck. Although a proportion of the bacteria sequestered within Kupffer cells are efficiently killed, a subpopulation of internalized S. aureus bacteria has been shown to survive and even multiply in the phagosomes and eventually kill the host cells (17). There, neutrophils take up the bacteria and may reenter circulation, thereby disseminating the pathogen from the liver to secondary infection sites (18). Thus, from the first niche in the liver, S. aureus disseminates to secondary infection niches such as the bones and kidneys, where distal abscesses are formed (6). It is thought that S. aureus requires different subsets of virulence factors to establish infection in the various niches it may encounter within the host.

Tn-Seq identified a niche-specific transcription factor.We hence used a transposon mutant library in S. aureus 6850 (19) to discover virulence factors critical for S. aureus to establish infection in secondary infection niches. Mice were intravenously inoculated with the transposon library and Tn-seq was applied to bacteria recovered from the primary infection site at the liver as well as from secondary infection sites at the kidneys to catalog the insertion mutants compared to the infection inoculum. Several genes were identified whose mutants were specifically depleted or enriched in either liver or kidney or in both organs of mice after experimental intravenous infection (Table 1; see also Tables S5 and S6 in the supplemental material).

Interestingly, the lists obtained by Tn insertion site sequencing do not contain classical (pore-forming) toxins such as staphylococcal alpha toxin or leukocidins, illustrating that the sequencing strategy would benefit from mutant libraries with higher complexities (12); however, the strategy is mostly limited by the strong selective effects. For instance, we initially tried to extend the Tn-Seq strategy to tibiae; however, the recovered number of bacteria was too low for analysis, thereby illustrating the strength of the bottleneck effects (data not shown).

We found only the RSAU_000852 mutant to be specifically depleted in secondary infection sites in kidneys in comparison with the original inoculated pool of mutants as well as with those mutants recovered from primary infection sites at the liver. These results indicate that expression of RSAU_000852 may be of critical importance for S. aureus to establish infection specifically in secondary niches within the host. This was corroborated by intravenous infection of mice with the seamless Δ852 deletion mutant deficient in the expression of RSAU_000852. Whereas the Δ852 mutant exhibited a significantly lower capacity to establish infection in kidneys and tibiae than WT bacteria, the number of Δ852 mutant bacteria recovered from liver was comparable to that of the WT strain. Furthermore, mice infected with the Δ852 mutant also exhibited significantly lower serum levels of the inflammatory cytokine IL-6 than those infected with the WT strain, which correlates with the attenuated phenotype of the mutant strain.

Characterization of the novel LTTR.Homology search identified a LysR-type transcriptional regulator (LTTR) as the product of RSAU_000852. LTTRs are known as the largest family of prokaryotic DNA-binding proteins, with 800 members identified on the basis of their amino acid sequence (20). They can act as either repressors or activators of single or operonic genes (21, 22). LTTRs regulate numerous genes whose products are involved in important bacterial functions such as metabolism, motility, cell division, quorum sensing, virulence, and oxidative stress response to name a few (23–31). Four LTTRs have been identified so far in S. aureus, including CidR, HutR, GltC, and CcpE (32–34). In this study, we have identified a new LTTR in S. aureus 6850 encoded by RSAU_000852, with unknown function and whose expression was rarely reported. For example, some studies have reported that RSAU_000852 was 2.94-fold downregulated in the presence of 0.01 μM linoleic acid (35) and 3.75-fold induced in strain COL exposed to 1 mM diamide (36). In other studies, however, where networks of gene regulation were investigated in S. aureus strain HG001 under 106 different conditions, the NCTC82325 LTTR_852 homolog, SAOUHSC_0913, was never found to be expressed under any of the conditions tested (37).

By using AHT-inducible expression of LTTR in S. aureus 6850 and subsequent RNA-seq, we established potential targets of the transcriptional regulator (Table 2). Genes found upregulated upon induction of LTTR expression included those encoding peptide methionine sulfoxide reductase msrA2 and components of a copper-translocation machinery, copA and the copper chaperone copZ (38), which are involved in copper efflux, as well as genes encoding factors involved in branched-chain amino acid biosynthesis such as ilvD (dihydroxy-acid dehydratase), ilvB, leuA2, and the holin-like murein hydrolase regulator lrgA. Oxidation of methionine by the activity of methionine sulfoxide reductase can destroy protein structure or affect protein function (39). There are four methionine sulfoxide reductases harbored by S. aureus, of which three possess MsrA functionality and a single gene encoding MsrB (40). Interestingly, the operon encoding msrA1 and msrB was found to be upregulated in S. aureus recovered from experimental animals during acute and chronic infection in comparison to S. aureus grown in medium in vitro (6). Our data suggest, however, that LTTR is specifically upregulating msrA2. Among the well-studied LTTRs is OxyR, which is responsible for the oxidative stress response against H2O2 in Escherichia coli and Salmonella enterica serovar Typhimurium (41). Peroxide is, for instance, produced as an antibacterial agent by many cells of the innate immune system. Hence, LTTR may be important for S. aureus upon encountering oxidative stress in the host.

Isopropylmalate synthase 2 encoded by leuA2 is involved in the first step of the pathway of l-leucine biosynthesis. leuA2 as well as other genes of the branched-chain amino acid (BCAA) biosynthesis machinery (leuC, leuD, leuB, and ilvE) and bcaP, a BCAA transporter (42), have been identified as target genes of LTTR by RNA-seq. Another virulence-associated BCAA transporter, brnQ2 (RSAU_000252), was reported to be upregulated in S. aureus during chronic infections, suggesting CodY derepression and emphasizing the importance of branched-chain amino acid metabolism for S. aureus survival within the host (6). brnQ1, brnQ2, or brnQ3 and other CodY targets, however, were not significantly regulated in our data set, suggesting that a CodY-independent induction of BCAA biosynthesis may exist in S. aureus. It has to be noted that transcription of LTTR was not derepressed in a codY mutant (43), although the promoter region of LTTR (within the intergenic region of the upstream gene clpB and RSAU_000852) was highly enriched in CodY chromatin precipitation analyses (43).

Genes with reduced expression after LTTR induction included members of the urease operon ureB, ureC, ureE, and ureF as well as genes of pyrimidine biosynthesis, pyrB, pyrC, and carB, suggesting that the de novo UMP biosynthesis pathway is repressed by LTTR. Urease is part of the of S. aureus response to acid shock and recently was shown to be required for bacterial persistence in murine kidney infection (44). lacC (tagatose-6-phosphate kinase) and the lactose-specific compound lacE (PTS lactose-specific transporter subunit IIBC) (45) were also found repressed by the LTTR. LacC is involved in synthesis of d-glyceraldehyde 3-phosphate and glycerone phosphate from d-tagatose 6-phosphate, and LacE is part of the phosphoenolpyruvate-dependent sugar phosphotransferase system (PTS; LacEF). Increased PTS expression has been hypothesized to facilitate the pathogenesis of S. aureus in mastitis (46) and may also facilitate S. aureus adaptation to secondary organs during bloodstream infection as shown in this study.

Overall, expression of potentially LTTR-regulated genes under induction conditions was not very high, although significant. We hypothesize that the lack of the specific coinducer that LysR-type transcriptional regulators usually require for their activity is responsible for this effect. Since LTTRs require coinducers for DNA binding or multimerization, we assume that the concentration of the hitherto unknown coinducer of LTTR was limiting under the conditions tested. LTTRs comprise an N-terminal helix-turn-helix (HTH) motif and a C-terminal LysR-substrate-binding region (20). Different coinducers with structural diversity (e.g., amino acid derivates, aromatics, ions, and various aliphatics) have been shown to be involved in the stimulation of various LTTRs (20). For example, the well-characterized LTTR ToxR of Burkholderia glumae activates local quorum sensing via toxoflavin (27). In rare cases, the coinducer operates as an activator and repressor such as α-methylene-γ-butyrolactone during pilus and capsule synthesis in Neisseria meningitidis (47). Certainly, not all cofactors are known; for example, for YofA involved in the cell division in Bacillus subtilis (30) and a Yersinia pestis corepressor (48), the cofactors remain unidentified. Further experiments will be required to identify the coinducer(s) of LTTR. The decreased fitness of a RSAU_000852 mutant in mouse kidneys and tibiae leads us to hypothesize that niche-specific molecules may account for full activity of the LTTR protein.

Regarding the microenvironments in which LTTR is induced, our data show that LTTR promoter activity specifically requires microaerobic and glucose-free conditions as well as low concentrations of copper ions. Kidneys are involved in glucose homeostasis through processes of gluconeogenesis, glucose filtration, reabsorption, and consumption (49). Modeling glucose metabolism in kidneys identified anaerobic glucose metabolism in the inner medulla, owing to the limited blood flow and low tissue oxygen tension (50). Thus, microenvironments exist in the kidneys that are compatible with promoter activity of RSAU_000852.

Furthermore, we identified copper as a limiting factor for the activation of LTTR transcription. Copper is a cofactor essential for many enzymes involved in a multitude of cellular functions of both host and pathogen, such as cellular respiration, iron transport, and free radical scavenging (51–53). Copper also serves as antibacterial agent and is pumped into phagosomes of macrophages in order to kill bacteria. S. aureus, in turn, possesses copper efflux pumps, which are involved in survival under high-copper stress. Recently, two novel genes were identified, copB and copL (54). copB functions in copper export and displayed genetic synergy with copA. The function of copL is independent of copA and copB, it is a membrane bound and surface-exposed lipoprotein that binds up to four Cu ions. Our data suggest that LTTR_852 not only is transcriptionally activated by low concentrations of copper ions but also is involved in copAZ expression and thereby can modulate the copper response of S. aureus.

LTTR promoter activity can be seen in multiple genetic backgrounds of S. aureus (see Fig. S4 in the supplemental material) Interestingly, copper depletion had no effect on the LTTR promoter activity in USA 300 JE2. USA 300 strains carry a copper resistance locus (copXL), uniquely associated with the staphylococcal cassette chromosome mec elements (SCCmecs) not found in other S. aureus lineages (55) (Fig. S4). copL encodes a membrane-bound and surface-exposed lipoprotein that binds up to four Cu+ ions (54) and, therefore, may supply copper to the bacterium after been transferred to a copper-depleted growth medium.

FIG S4

LTTR promoter activity in different S. aureus strains in CDM under various conditions. GFP/OD Ratios of S. aureus 6850 (A), USA 300 JE2 (B), Cowan I (C), and RN4220 (D) in CDM under microaerobic conditions (black), CDM without glucose under microaerobic (green), and aerobic conditions (red), as well as in medium without glucose and copper sulfate (blue). All experiments were performed in triplicates (n = 3). Download FIG S4, PDF file, 0.2 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

RNA-seq after induced expression of LTTR suggested the oxidative stress response gene msrA as a target gene. We therefore hypothesized that LTTR may be important for S. aureus upon encounter of oxidative stress in the host (see above). Interestingly, we show induction of the LTTR gene RSAU_000852 under H2O2 stress, which is absent in the Δ852 mutant yet reinstated by supplying the locus in trans.

Taken together, our data show that the LTTR encoded by RSAU_000852 is a transcriptional regulator required in specific host niches for the efficient establishment of infection. Within this niche, glucose and oxygen are limited, copper ions must be present, and reactive oxygen concentrations may be elevated, possibly due to recruited immune cells.

A limitation of the study is that we conducted Tn-Seq in a S. aureus pool of mutants recovered from liver and kidneys of intravenously infected animals. We identified the regulator LTTR as important for colonization of secondary organs (kidneys and bones) but not for establishment of infection in the primary site of infection at the liver. Since we harvested the infected tissues at a single time point very early during infection (24 h), we cannot exclude a potential role of LTTR for bacterial survival in the liver at later times of infection.

In summary, we identified in this study a LysR-type transcriptional regulator in S. aureus that is required for bacterial colonization of secondary infection sites. We unveiled a complex dependency of transcriptional activation of the regulator gene and, by inducible expression, identified a set of potentially regulated genes, which includes genes required to cope with oxidative stress and for growth under low-oxygen and glucose-free conditions, such as those found in host tissues. Hence, we hypothesize that the LTTR may play an important role in metabolic adaptation of S. aureus to local infection sites in the host. Thus, therapeutic targeting of the novel regulatory factor identified in this study in patients with S. aureus bacteremia may result in reduced bacterial fitness and offer options for improving disease outcome.

MATERIALS AND METHODS

Mice and infection model.Pathogen-free 10-week-old female C57BL/6 mice (20.5 ± 0.8 g body weight) were purchased from Harlan-Winkelmann (Envigo, The Netherlands). Mice were infected intravenously with 106 CFU of S. aureus strain 6850 in 100 ml of phosphate-buffered saline (PBS) via a lateral tail vein. For determination of bacterial numbers in organs, mice were killed by CO2 asphyxiation at a specified time after bacterial inoculation, and organs were removed and homogenized in PBS. Serial 10-fold dilutions of organ homogenates were plated on blood agar plates. Bacterial colonies were counted after incubation at 37°C for 24 h and calculated as CFU per organ or per mg of bone. Animal experiments were performed in strict accordance with the German regulations of the Society for Laboratory Animal Science (GV-SOLAS) and the European Health Law of the Federation of Laboratory Animal Science Associations (FELASA), and animals were excluded from further analysis if killing was necessary according to the humane endpoints established by the ethical board. All experiments were approved by the ethical board Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany (LAVES; permit number 33.9-42502-04-13/1195).

ELISA.The concentration of IL-6 in serum of infected mice was determined by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s recommendations (BD Biosciences).

Bacterial culture.S. aureus strains (see Table S1 in the supplemental material) were grown in Trypticase soy broth (TSB), lysogeny broth (LB), or chemically defined medium (CDM) using appropriate antibiotics. The Tn-Seq inoculum was prepared by growing the strains in brain heart infusion (BHI) to an optical density (OD) of 0.5 before they were washed with PBS, aliquoted, and stored at −80°C.

TABLE S1

Bacterial strains and plasmids used in this study. Download Table S1, PDF file, 0.2 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

CDM contained final concentrations of 1× basic medium (12.5 mM Na2HPO4·2H2O, 10 mM KH2PO4, 1.65 mM MgSO4, 9.25 mM NH4Cl, 8.5 mM NaCl), 75 mM glucose, 0.142 mM sodium citrate tribasic dihydrate, and 1 mM each amino acid except for tyrosine (0.1 mM). The trace element mix A5 was purchased from Sigma-Aldrich (number 92949) and was supplemented with FeCl3 in NaOH and 0.1 μM NiCl2. Vitamin mix contained final concentrations of 0.29 μM 4-aminobenzoic acid, 0.29 μM thiamine hydrochloride, 0.21 μM Ca-d-pantothenic acid, 0.036 μM cyanocobalamin, 0.04 μM d-biotin, 0.81 μM nicotinamide, 0.62 μM pyridoxine hydrochloride, and 0.2 μM riboflavin.

For induction of LTTR expression by anhydrous tetracycline, overnight cultures were diluted in 10 ml fresh TSB containing 200 ng/ml anhydrous tetracycline and were incubated at 37°C at 750 rpm for 1 h. Bacteria were harvested and snap-frozen in liquid nitrogen.

Promoter activity assays.Promoter activities during bacterial growth were assessed by monitoring GFP fluorescence (excitation, 488 ± 9 nm; emission, 518 ± 20 nm) as well as optical density (at 600 nm) using a Tecan Infinite M200 multiplate reader. For this, bacteria were grown in either TSB, LB, CDM, or CDM without glucose overnight at 37°C at 180 rpm in the presence of 20 μg/ml chloramphenicol. If medium exchange was necessary, overnight cultures where washed once with PBS and were resuspended in the corresponding medium. Bacterial suspensions with an OD of 0.1 were added to a 48-well microtiter plate (400 μl/well) and further cultured 6 h or 24 h under aerobic and microaerobic conditions. A microaerobic atmosphere was established by sealing the microtiter plates with adhesive foil and thereby limiting oxygen availability. Microaerobic conditions were confirmed by the relative induction of the gene encoding formate acetyltransferase (pflB), which is expressed only under low oxygen conditions (56). Absorbance and GFP fluorescence were recorded every 10 min using a Tecan Infinite M200 multiplate reader and were evaluated using Microsoft Excel.

Staphylococcus aureus Tn-Seq.Pooled mariner transposon mutant libraries were generated as previously described (11, 57). Bacterial DNA was isolated from the infection inoculum and from the bacterial colonies derived from infected tissues as previously described (11). The libraries were sequenced on the Illumina Hi-Seq 2500 platform with the transposon-specific oligonucleotide primer Himar1-Seq (11). Illumina adapter sequences were removed via cutadapt version 1.2.1 (58). The reads also were filtered for size (>16 bp) and to contain the transposon inverted terminal repeat (ITR) and were mapped to the Staphylococcus aureus 6850 genome (RefSeq accession NC_022222.1) by Bowtie2 v2.1.0 (59). Identification of depleted and enriched mutants was performed via DESeq2 version 1.6.2 (60).

Cloning procedures.Chromosomal DNA of S. aureus was prepared using the QIAprep Spin miniprep kit from Qiagen with the following modification: after resuspension of the bacteria in buffer P1, we added 50 μl lysostaphin and incubated at 37°C for 30 min (750 rpm).

For deletion of RSAU_000852 in S. aureus 6850, regions approximately 1 kb upstream and downstream were amplified by PCR using primers attB1-852-up-F and 852-up-R-SacII as well as 852-down-F-SacII and attB2-852-down-R, respectively (Table S2). The PCR product was cloned into pKOR1, and a markerless targeted gene deletion was then generated as previously described (61). To exclude relevant secondary site mutations, we sequenced the genome of the mutant (https://www.eurofinsgenomics.eu/). Sequence reads were mapped to the genome sequence of the wild-type S. aureus 6850 genome (RefSeq accession NC_022222.1).

TABLE S2

Oligonucleotides used in this study. Download Table S2, PDF file, 0.10 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S3

Enrichment in GO terms as determined by https://string-db.org/. Download Table S3, PDF file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S4

Gene mutants identified enriched or depleted in murine liver after intravenous infection (cutoff, adj. P values of ≤0.0005). Download Table S4, PDF file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S5

S. aureus transposon mutants found either enriched or depleted in kidneys and/or livers of mice after intravenous infection by using TN-seq. Counts of sequenced transposon insertion sites were compared with the counts obtained from the infection inoculum. By comparing the inoculum to the recovered samples, genes which are lost in a specific tissue are represented by negative log2FC and vice versa. Download Table S5, PDF file, 0.6 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

TABLE S6

S. aureus transposon mutants identified by Tn-seq with sequence reads enriched (positive log2 fold changes [log2FC]) or depleted (negative log2FC) in either kidneys or livers of mice 24 h after intravenous infection compared to the infection inoculum (adjusted P value cutoff of 0.05). Shown are the open reading frame (ORF) ID of strain 6850 as well as its homolog within strain NCTC8325, gene assignment, annotation, log2FC, and adjusted P value of reads obtained from bacteria recovered from infected kidneys and livers. Genes that were identified as infection relevant in a previous study (67) are indicated. Download Table S6, XLSX file, 0.1 MB.
Copyright © 2020 Groma et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

The RSAU_000852 ORF was amplified from S. aureus genomic DNA using oligonucleotides 852-NotI-F and 852-BamHI-R (Table S2). Plasmid p2085-852, allowing for anhydrous tetracycline-inducible expression of RSAU_000852, was generated by restricting the PCR product as well as the vector, p2085 (62), with BamHI and NotI and subsequent ligation of vector and insert. The resulting plasmid was transformed into E. coli DH5α and plated on LB agar supplemented with ampicillin. The plasmid isolated from E. coli was sequenced, propagated within the cloning strain S. aureus RN4220, and transformed into electrocompetent S. aureus 6850.

For generation of the LTTR promoter (pr852) activity construct, p2085 was amplified using oligonucleotides pGFP-Inf-Prom-F and pGFP-vec-R (Table S2). pr852 was amplified from S. aureus DNA using oligonucleotides pGFP_852-Prom_fw and pGFP_852-Prom_rev. This fragment was cloned in the linearized vector using infusion cloning, transformed into E. coli DH5α, and plated on LB agar plates supplemented with 100 μg/ml ampicillin. The plasmid was isolated from E. coli, and the insert sequence was verified by Sanger sequencing, electroporated into S. aureus RN4220, and finally transferred to S. aureus 6850 by phage transduction.

RNA-seq.RNA was isolated from S. aureus using TRIzol as previously described (63). DNase I treatment was performed to remove remaining DNA. The concentration of the RNA was determined by spectrophotometry on a NanoDrop 1000 (Peqlab), and RNA integrity was examined using agarose gel containing formamide or by analysis via Bioanalyzer. Enrichment of mRNA was performed using the Universal Ribodepletion kit followed by Next Ultra Directional Library Preparation kit for Illumina (NEB). The cDNA was sequenced on a HiSeq 2500 (Illumina) yielding 100-bp paired-end reads. Adapters were removed using cutadapt (64), and only reads exceeding a mean base quality 5 within all sliding windows of 5 bp were mapped to the S. aureus 6850 genome (NCBI accession NC_022222 [65]). Read mapping was conducted using Bowtie2 (66). DESeq2 (60) was used to identify differentially regulated transcripts.

qRT-PCR.Reverse transcription of total isolated RNA was performed using RevertAID reverse transcriptase (Thermo Scientific). A 10-ng sample of cDNA was used to perform quantitative RT-PCR (qRT-PCR) in a one-step reaction using Sybr green master mix (Genaxxon) on a StepOne Plus real-time PCR system (Applied Biosystems). For primers used for qRT-PCR, see Table S2. Analysis was performed using the comparative threshold cycle (2−ΔΔCT) method. Relative gene expression was normalized to expression of gyrB and to the corresponding expression under control conditions.

Statistics.Data were analyzed by Microsoft Excel and GraphPad Prism. Significance of differences from at least three independent replicates were determined by a Student’s t test for comparison of two independent data sets or with one-way analysis of variance (ANOVA) followed by Tukey’s multiple-comparison test for comparison of three independent data sets.

ACKNOWLEDGMENTS

This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG], www.dfg.de) within the Collaborative Research Center TRR34 under code P11 to M.F. and T.R. and the University of Würzburg, funding program Open Access Publishing.

We thank Kerstin Paprotka and Linda Raupach for initial molecular cloning.

FOOTNOTES

    • Received 19 June 2020
    • Accepted 17 July 2020
    • Published 25 August 2020
  • Copyright © 2020 Groma et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

REFERENCES

  1. 1.↵
    1. Boucher H,
    2. Miller LG,
    3. Razonable RR
    . 2010. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 51 Suppl 2:S183–S197. doi:10.1086/653519.
    OpenUrlCrossRef
  2. 2.↵
    1. Lowy FD
    . 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273. doi:10.1172/JCI18535.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Foster TJ
    . 2005. Immune evasion by staphylococci. Nat Rev Microbiol 3:948–958. doi:10.1038/nrmicro1289.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Thomer L,
    2. Schneewind O,
    3. Missiakas D
    . 2016. Pathogenesis of Staphylococcus aureus bloodstream infections. Annu Rev Pathol 11:343–364. doi:10.1146/annurev-pathol-012615-044351.
    OpenUrlCrossRef
  5. 5.↵
    1. Edwards AM,
    2. Potts JR,
    3. Josefsson E,
    4. Massey RC
    . 2010. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog 6:e1000964. doi:10.1371/journal.ppat.1000964.
    OpenUrlCrossRef
  6. 6.↵
    1. Szafranska AK,
    2. Oxley APA,
    3. Chaves-Moreno D,
    4. Horst SA,
    5. Roßlenbroich S,
    6. Peters G,
    7. Goldmann O,
    8. Rohde M,
    9. Sinha B,
    10. Pieper DH,
    11. Löffler B,
    12. Jauregui R,
    13. Wos-Oxley ML,
    14. Medina E
    . 2014. High-resolution transcriptomic analysis of the adaptive response of Staphylococcus aureus during acute and chronic phases of osteomyelitis. mBio 5:e01775-14. doi:10.1128/mBio.01775-14.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Thanert R,
    2. Goldmann O,
    3. Beineke A,
    4. Medina E
    . 2017. Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection. Nat Commun 8:14268. doi:10.1038/ncomms14268.
    OpenUrlCrossRef
  8. 8.↵
    1. van Opijnen T,
    2. Bodi KL,
    3. Camilli A
    . 2009. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 6:767–772. doi:10.1038/nmeth.1377.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Forsyth RA,
    2. Haselbeck RJ,
    3. Ohlsen KL,
    4. Yamamoto RT,
    5. Xu H,
    6. Trawick JD,
    7. Wall D,
    8. Wang L,
    9. Brown-Driver V,
    10. Froelich JM,
    11. C KG,
    12. King P,
    13. McCarthy M,
    14. Malone C,
    15. Misiner B,
    16. Robbins D,
    17. Tan Z,
    18. Zhu Zy ZY,
    19. Carr G,
    20. Mosca DA,
    21. Zamudio C,
    22. Foulkes JG,
    23. Zyskind JW
    . 2002. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol 43:1387–1400. doi:10.1046/j.1365-2958.2002.02832.x.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Akerley BJ,
    2. Rubin EJ,
    3. Novick VL,
    4. Amaya K,
    5. Judson N,
    6. Mekalanos JJ
    . 2002. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci U S A 99:966–971. doi:10.1073/pnas.012602299.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Das S,
    2. Lindemann C,
    3. Young BC,
    4. Muller J,
    5. Osterreich B,
    6. Ternette N,
    7. Winkler AC,
    8. Paprotka K,
    9. Reinhardt R,
    10. Forstner KU,
    11. Allen E,
    12. Flaxman A,
    13. Yamaguchi Y,
    14. Rollier CS,
    15. van Diemen P,
    16. Blattner S,
    17. Remmele CW,
    18. Selle M,
    19. Dittrich M,
    20. Muller T,
    21. Vogel J,
    22. Ohlsen K,
    23. Crook DW,
    24. Massey R,
    25. Wilson DJ,
    26. Rudel T,
    27. Wyllie DH,
    28. Fraunholz MJ
    . 2016. Natural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation. Proc Natl Acad Sci U S A 113:E3101–E3110. doi:10.1073/pnas.1520255113.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Santiago M,
    2. Matano LM,
    3. Moussa SH,
    4. Gilmore MS,
    5. Walker S,
    6. Meredith TC
    . 2015. A new platform for ultra-high density Staphylococcus aureus transposon libraries. BMC Genomics 16:252. doi:10.1186/s12864-015-1361-3.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Horst SA,
    2. Hoerr V,
    3. Beineke A,
    4. Kreis C,
    5. Tuchscherr L,
    6. Kalinka J,
    7. Lehne S,
    8. Schleicher I,
    9. Kohler G,
    10. Fuchs T,
    11. Raschke MJ,
    12. Rohde M,
    13. Peters G,
    14. Faber C,
    15. Loffler B,
    16. Medina E
    . 2012. A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. Am J Pathol 181:1206–1214. doi:10.1016/j.ajpath.2012.07.005.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Giese B,
    2. Dittmann S,
    3. Paprotka K,
    4. Levin K,
    5. Weltrowski A,
    6. Biehler D,
    7. Lam TT,
    8. Sinha B,
    9. Fraunholz MJ
    . 2009. Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells. Infect Immun 77:3611–3625. doi:10.1128/IAI.01478-08.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Paprotka K,
    2. Giese B,
    3. Fraunholz MJ
    . 2010. Codon-improved fluorescent proteins in investigation of Staphylococcus aureus host pathogen interactions. J Microbiol Methods 83:82–86. doi:10.1016/j.mimet.2010.07.022.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Epstein FH
    . 1997. Oxygen and renal metabolism. Kidney Int 51:381–385. doi:10.1038/ki.1997.50.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Surewaard BG,
    2. Deniset JF,
    3. Zemp FJ,
    4. Amrein M,
    5. Otto M,
    6. Conly J,
    7. Omri A,
    8. Yates RM,
    9. Kubes P
    . 2016. Identification and treatment of the Staphylococcus aureus reservoir in vivo. J Exp Med 213:1141–1151. doi:10.1084/jem.20160334.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Pollitt EJG,
    2. Szkuta PT,
    3. Burns N,
    4. Foster SJ
    . 2018. Staphylococcus aureus infection dynamics. PLoS Pathog 14:e1007112. doi:10.1371/journal.ppat.1007112.
    OpenUrlCrossRef
  19. 19.↵
    1. Vann JM,
    2. Proctor RA
    . 1987. Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun 55:2155–2163. doi:10.1128/IAI.55.9.2155-2163.1987.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Schell MA
    . 1993. Molecular biology of the LysR family of transcriptional regulators. Annu Rev Microbiol 47:597–626. doi:10.1146/annurev.mi.47.100193.003121.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Heroven AK,
    2. Dersch P
    . 2006. RovM, a novel LysR-type regulator of the virulence activator gene rovA, controls cell invasion, virulence and motility of Yersinia pseudotuberculosis. Mol Microbiol 62:1469–1483. doi:10.1111/j.1365-2958.2006.05458.x.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Hernández-Lucas I,
    2. Gallego-Hernández AL,
    3. Encarnación S,
    4. Fernández-Mora M,
    5. Martínez-Batallar AG,
    6. Salgado H,
    7. Oropeza R,
    8. Calva E
    . 2008. The LysR-type transcriptional regulator LeuO controls expression of several genes in Salmonella enterica serovar Typhi. J Bacteriol 190:1658–1670. doi:10.1128/JB.01649-07.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Kovacikova G,
    2. Skorupski K
    . 1999. A Vibrio cholerae LysR homolog, AphB, cooperates with AphA at the tcpPH promoter to activate expression of the ToxR virulence cascade. J Bacteriol 181:4250–4256. doi:10.1128/JB.181.14.4250-4256.1999.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Deghmane AE,
    2. Petit S,
    3. Topilko A,
    4. Pereira Y,
    5. Giorgini D,
    6. Larribe M,
    7. Taha MK
    . 2000. Intimate adhesion of Neisseria meningitidis to human epithelial cells is under the control of the crgA gene, a novel LysR-type transcriptional regulator. EMBO J 19:1068–1078. doi:10.1093/emboj/19.5.1068.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Deghmane AE,
    2. Giorgini D,
    3. Larribe M,
    4. Alonso JM,
    5. Taha MK
    . 2002. Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol 43:1555–1564. doi:10.1046/j.1365-2958.2002.02838.x.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Cao H,
    2. Krishnan G,
    3. Goumnerov B,
    4. Tsongalis J,
    5. Tompkins R,
    6. Rahme LG
    . 2001. A quorum sensing-associated virulence gene of Pseudomonas aeruginosa encodes a LysR-like transcription regulator with a unique self-regulatory mechanism. Proc Natl Acad Sci U S A 98:14613–14618. doi:10.1073/pnas.251465298.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Kim J,
    2. Kim JG,
    3. Kang Y,
    4. Jang JY,
    5. Jog GJ,
    6. Lim JY,
    7. Kim S,
    8. Suga H,
    9. Nagamatsu T,
    10. Hwang I
    . 2004. Quorum sensing and the LysR-type transcriptional activator ToxR regulate toxoflavin biosynthesis and transport in Burkholderia glumae. Mol Microbiol 54:921–934. doi:10.1111/j.1365-2958.2004.04338.x.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Russell DA,
    2. Byrne GA,
    3. O'Connell EP,
    4. Boland CA,
    5. Meijer WG
    . 2004. The LysR-type transcriptional regulator VirR is required for expression of the virulence gene vapA of Rhodococcus equi ATCC 33701. J Bacteriol 186:5576–5584. doi:10.1128/JB.186.17.5576-5584.2004.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Byrne GA,
    2. Russell DA,
    3. Chen X,
    4. Meijer WG
    . 2007. Transcriptional regulation of the virR operon of the intracellular pathogen Rhodococcus equi. J Bacteriol 189:5082–5089. doi:10.1128/JB.00431-07.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Lu Z,
    2. Takeuchi M,
    3. Sato T
    . 2007. The LysR-type transcriptional regulator YofA controls cell division through the regulation of expression of ftsW in Bacillus subtilis. J Bacteriol 189:5642–5651. doi:10.1128/JB.00467-07.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Sperandio B,
    2. Gautier C,
    3. McGovern S,
    4. Ehrlich DS,
    5. Renault P,
    6. Martin-Verstraete I,
    7. Guédon E
    . 2007. Control of methionine synthesis and uptake by MetR and homocysteine in Streptococcus mutans. J Bacteriol 189:7032–7044. doi:10.1128/JB.00703-07.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Yang SJ,
    2. Rice KC,
    3. Brown RJ,
    4. Patton TG,
    5. Liou LE,
    6. Park YH,
    7. Bayles KW
    . 2005. A LysR-type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon. J Bacteriol 187:5893–5900. doi:10.1128/JB.187.17.5893-5900.2005.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Ibarra JA,
    2. Perez-Rueda E,
    3. Carroll RK,
    4. Shaw LN
    . 2013. Global analysis of transcriptional regulators in Staphylococcus aureus. BMC Genomics 14:126. doi:10.1186/1471-2164-14-126.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Hartmann T,
    2. Zhang B,
    3. Baronian G,
    4. Schulthess B,
    5. Homerova D,
    6. Grubmuller S,
    7. Kutzner E,
    8. Gaupp R,
    9. Bertram R,
    10. Powers R,
    11. Eisenreich W,
    12. Kormanec J,
    13. Herrmann M,
    14. Molle V,
    15. Somerville GA,
    16. Bischoff M
    . 2013. Catabolite control protein E (CcpE) is a LysR-type transcriptional regulator of tricarboxylic acid cycle activity in Staphylococcus aureus. J Biol Chem 288:36116–36128. doi:10.1074/jbc.M113.516302.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Kenny JG,
    2. Ward D,
    3. Josefsson E,
    4. Jonsson IM,
    5. Hinds J,
    6. Rees HH,
    7. Lindsay JA,
    8. Tarkowski A,
    9. Horsburgh MJ
    . 2009. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 4:e4344. doi:10.1371/journal.pone.0004344.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Posada AC,
    2. Kolar SL,
    3. Dusi RG,
    4. Francois P,
    5. Roberts AA,
    6. Hamilton CJ,
    7. Liu GY,
    8. Cheung A
    . 2014. Importance of bacillithiol in the oxidative stress response of Staphylococcus aureus. Infect Immun 82:316–332. doi:10.1128/IAI.01074-13.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Mäder U,
    2. Nicolas P,
    3. Depke M,
    4. Pané-Farré J,
    5. Debarbouille M,
    6. van der Kooi-Pol MM,
    7. Guérin C,
    8. Dérozier S,
    9. Hiron A,
    10. Jarmer H,
    11. Leduc A,
    12. Michalik S,
    13. Reilman E,
    14. Schaffer M,
    15. Schmidt F,
    16. Bessières P,
    17. Noirot P,
    18. Hecker M,
    19. Msadek T,
    20. Völker U,
    21. van Dijl JM
    . 2016. Staphylococcus aureus transcriptome architecture: from laboratory to infection-mimicking conditions. PLoS Genet 12:e1005962. doi:10.1371/journal.pgen.1005962.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Sitthisak S,
    2. Knutsson L,
    3. Webb JW,
    4. Jayaswal RK
    . 2007. Molecular characterization of the copper transport system in Staphylococcus aureus. Microbiology 153:4274–4283. doi:10.1099/mic.0.2007/009860-0.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Stadtman ER,
    2. Moskovitz J,
    3. Levine RL
    . 2003. Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal 5:577–582. doi:10.1089/152308603770310239.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Singh VK,
    2. Singh K,
    3. Baum K
    . 2018. The role of methionine sulfoxide reductases in oxidative stress tolerance and virulence of Staphylococcus aureus and other bacteria. Antioxidants (Basel) 7:128. doi:10.3390/antiox7100128.
    OpenUrlCrossRef
  41. 41.↵
    1. Farr SB,
    2. Kogoma T
    . 1991. Oxidative stress responses in Escherichia coli and Salmonella Typhimurium. Microbiol Rev 55:561–585. doi:10.1128/MMBR.55.4.561-585.1991.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Kaiser JC,
    2. King AN,
    3. Grigg JC,
    4. Sheldon JR,
    5. Edgell DR,
    6. Murphy MEP,
    7. Brinsmade SR,
    8. Heinrichs DE
    . 2018. Repression of branched-chain amino acid synthesis in Staphylococcus aureus is mediated by isoleucine via CodY, and by a leucine-rich attenuator peptide. PLoS Genet 14:e1007159. doi:10.1371/journal.pgen.1007159.
    OpenUrlCrossRef
  43. 43.↵
    1. Majerczyk CD,
    2. Dunman PM,
    3. Luong TT,
    4. Lee CY,
    5. Sadykov MR,
    6. Somerville GA,
    7. Bodi K,
    8. Sonenshein AL
    . 2010. Direct targets of CodY in Staphylococcus aureus. J Bacteriol 192:2861–2877. doi:10.1128/JB.00220-10.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Zhou C,
    2. Bhinderwala F,
    3. Lehman MK,
    4. Thomas VC,
    5. Chaudhari SS,
    6. Yamada KJ,
    7. Foster KW,
    8. Powers R,
    9. Kielian T,
    10. Fey PD
    . 2019. Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection. PLoS Pathog 15:e1007538. doi:10.1371/journal.ppat.1007538.
    OpenUrlCrossRef
  45. 45.↵
    1. Breidt F, Jr.,
    2. Hengstenberg W,
    3. Finkeldei U,
    4. Stewart GC
    . 1987. Identification of the genes for the lactose-specific components of the phosphotransferase system in the lac operon of Staphylococcus aureus. J Biol Chem 262:16444–16449.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Sharer MV,
    2. Su C,
    3. Hegde NV,
    4. Jayarao BM,
    5. Sordillo LM
    . 2003. Differential expression of the lactose transporter gene affects growth of Staphylococcus aureus in milk. J Dairy Sci 86:2373–2381. doi:10.3168/jds.S0022-0302(03)73831-4.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Ieva R,
    2. Alaimo C,
    3. Delany I,
    4. Spohn G,
    5. Rappuoli R,
    6. Scarlato V
    . 2005. CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription. J Bacteriol 187:3421–3430. doi:10.1128/JB.187.10.3421-3430.2005.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Heroven AK,
    2. Bohme K,
    3. Tran-Winkler H,
    4. Dersch P
    . 2007. Regulatory elements implicated in the environmental control of invasin expression in enteropathogenic Yersinia. Adv Exp Med Biol 603:156–166. doi:10.1007/978-0-387-72124-8_13.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Mather A,
    2. Pollock C
    . 2011. Glucose handling by the kidney. Kidney Int Suppl 2011:S1–S6. doi:10.1038/ki.2010.509.
    OpenUrlCrossRef
  50. 50.↵
    1. Chen Y,
    2. Fry BC,
    3. Layton AT
    . 2016. Modeling glucose metabolism in the kidney. Bull Math Biol 78:1318–1336. doi:10.1007/s11538-016-0188-7.
    OpenUrlCrossRef
  51. 51.↵
    1. Festa RA,
    2. Thiele DJ
    . 2011. Copper: an essential metal in biology. Curr Biol 21:R877–R883. doi:10.1016/j.cub.2011.09.040.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Collins JF,
    2. Prohaska JR,
    3. Knutson MD
    . 2010. Metabolic crossroads of iron and copper. Nutr Rev 68:133–147. doi:10.1111/j.1753-4887.2010.00271.x.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Jimenez I,
    2. Speisky H
    . 2000. Effects of copper ions on the free radical-scavenging properties of reduced gluthathione: implications of a complex formation. J Trace Elem Med Biol 14:161–167. doi:10.1016/S0946-672X(00)80005-X.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Rosario-Cruz Z,
    2. Eletsky A,
    3. Daigham NS,
    4. Al-Tameemi H,
    5. Swapna GVT,
    6. Kahn PC,
    7. Szyperski T,
    8. Montelione GT,
    9. Boyd JM
    . 2019. The copBL operon protects Staphylococcus aureus from copper toxicity: CopL is an extracellular membrane-associated copper-binding protein. J Biol Chem 294:4027–4044. doi:10.1074/jbc.RA118.004723.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Purves J,
    2. Thomas J,
    3. Riboldi GP,
    4. Zapotoczna M,
    5. Tarrant E,
    6. Andrew PW,
    7. Londono A,
    8. Planet PJ,
    9. Geoghegan JA,
    10. Waldron KJ,
    11. Morrissey JA
    . 2018. A horizontally gene transferred copper resistance locus confers hyper-resistance to antibacterial copper toxicity and enables survival of community acquired methicillin-resistant Staphylococcus aureus USA300 in macrophages. Environ Microbiol 20:1576–1589. doi:10.1111/1462-2920.14088.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Fuchs S,
    2. Pane-Farre J,
    3. Kohler C,
    4. Hecker M,
    5. Engelmann S
    . 2007. Anaerobic gene expression in Staphylococcus aureus. J Bacteriol 189:4275–4289. doi:10.1128/JB.00081-07.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Li M,
    2. Rigby K,
    3. Lai Y,
    4. Nair V,
    5. Peschel A,
    6. Schittek B,
    7. Otto M
    . 2009. Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids. Antimicrob Agents Chemother 53:4200–4210. doi:10.1128/AAC.00428-09.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. Martin JA,
    2. Wang Z
    . 2011. Next-generation transcriptome assembly. Nat Rev Genet 12:671–682. doi:10.1038/nrg3068.
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. Langmead B,
    2. Salzberg SL
    . 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi:10.1038/nmeth.1923.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Love MI,
    2. Huber W,
    3. Anders S
    . 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. doi:10.1186/s13059-014-0550-8.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Bae T,
    2. Schneewind O
    . 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58–63. doi:10.1016/j.plasmid.2005.05.005.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    1. Giese B,
    2. Glowinski F,
    3. Paprotka K,
    4. Dittmann S,
    5. Steiner T,
    6. Sinha B,
    7. Fraunholz MJ
    . 2011. Expression of delta-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of beta-toxin. Cell Microbiol 13:316–329. doi:10.1111/j.1462-5822.2010.01538.x.
    OpenUrlCrossRefPubMed
  63. 63.↵
    1. Lasa I,
    2. Toledo-Arana A,
    3. Dobin A,
    4. Villanueva M,
    5. de los Mozos IR,
    6. Vergara-Irigaray M,
    7. Segura V,
    8. Fagegaltier D,
    9. Penades JR,
    10. Valle J,
    11. Solano C,
    12. Gingeras TR
    . 2011. Genome-wide antisense transcription drives mRNA processing in bacteria. Proc Natl Acad Sci U S A 108:20172–20177. doi:10.1073/pnas.1113521108.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Martin M
    . 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal 17:10–12. doi:10.14806/ej.17.1.200.
    OpenUrlCrossRefPubMed
  65. 65.↵
    1. Fraunholz M,
    2. Bernhardt J,
    3. Schuldes J,
    4. Daniel R,
    5. Hecker M,
    6. Sinha B
    . 2013. Complete genome sequence of Staphylococcus aureus 6850, a highly cytotoxic and clinically virulent methicillin-sensitive strain with distant relatedness to prototype strains. Genome Announc 1:e00775-13. doi:10.1128/genomeA.00775-13.
    OpenUrlAbstract/FREE Full Text
  66. 66.↵
    1. Langmead B,
    2. Trapnell C,
    3. Pop M,
    4. Salzberg SL
    . 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. doi:10.1186/gb-2009-10-3-r25.
    OpenUrlCrossRefPubMed
  67. 67.↵
    1. Valentino MD,
    2. Foulston L,
    3. Sadaka A,
    4. Kos VN,
    5. Villet RA,
    6. Santa Maria J, Jr.,
    7. Lazinski DW,
    8. Camilli A,
    9. Walker S,
    10. Hooper DC,
    11. Gilmore MS
    . 2014. Genes contributing to Staphylococcus aureus fitness in abscess- and infection-related ecologies. mBio 5:e01729-14. doi:10.1128/mBio.01729-14.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Identification of a Novel LysR-Type Transcriptional Regulator in Staphylococcus aureus That Is Crucial for Secondary Tissue Colonization during Metastatic Bloodstream Infection
Michaela Groma, Sarah A. Horst, Sudip Das, Bruno Huettel, Maximilian Klepsch, Thomas Rudel, Eva Medina, Martin Fraunholz
mBio Aug 2020, 11 (4) e01646-20; DOI: 10.1128/mBio.01646-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of a Novel LysR-Type Transcriptional Regulator in Staphylococcus aureus That Is Crucial for Secondary Tissue Colonization during Metastatic Bloodstream Infection
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of a Novel LysR-Type Transcriptional Regulator in Staphylococcus aureus That Is Crucial for Secondary Tissue Colonization during Metastatic Bloodstream Infection
Michaela Groma, Sarah A. Horst, Sudip Das, Bruno Huettel, Maximilian Klepsch, Thomas Rudel, Eva Medina, Martin Fraunholz
mBio Aug 2020, 11 (4) e01646-20; DOI: 10.1128/mBio.01646-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Staphylococcus aureus
metabolic adaptation
secondary site infection
transcriptional regulation

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511